Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Aaron R Weiss

13PUBLICATIONS
46CO-AUTHORS
Molecular targetsPredictive and prognostic markersRadiation therapySolid tumoursEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

Sort by Publication Date:
|Jun 28, 2024
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.

Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane

|May 17, 2024
Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332.

David P Douglass, Cheryl M Coffin, R Lor Randall

|Apr 17, 2024
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group.

Jonathan Metts, Wei Xue, Zhengya Gao

|Apr 03, 2024
Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children's Oncology Group study ARST0332.

Sheri L Spunt, Wei Xue, Zhengya Gao

|Mar 12, 2024
Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children's Oncology Group.

Sapna Oberoi, Amira Qumseya, Wei Xue

|Jan 28, 2024
Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Douglas J Harrison, Amira Qumseya, Wei Xue

Pageof 3

Frequent Collaborators

3 joint publications

Sapna Oberoi

3 joint publications

Sheri L Spunt

2 joint publications

David P Douglass

2 joint publications

Jonathan Metts

2 joint publications

Douglas S Hawkins

2 joint publications

Douglas J Harrison

2 joint publications

Lynn Million

1 joint publications

Fariba Navid

1 joint publications

Noah Federman

1 joint publications

Jennifer O Black

Frequent Collaborators

3 joint publications

Sapna Oberoi

3 joint publications

Sheri L Spunt

2 joint publications

David P Douglass

2 joint publications

Jonathan Metts

Top Related Videos

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on : Jan 13, 2023

2.3K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on : May 03, 2021

3.6K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.4K
See more related videos

Top Related Videos

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on : Jan 13, 2023

2.3K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on : May 03, 2021

3.6K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.4K
See more related videos